CAV3 and type 2 diabetes mellitus: We monitored total FAT/CD36 and caveolin 3 expression in Control derived from four different healthy subjects (1 to 4) and in OBT2D derived from three obese type 2 diabetic patients (1 to 3) cells before fractionation (Fig. 1 C, top panels).